{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T05:14:41Z","timestamp":1783574081783,"version":"3.55.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T00:00:00Z","timestamp":1783555200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Nutr."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Serum albumin is widely used in clinical practice as a nutrition-related biomarker, yet in sepsis its concentration is strongly influenced by inflammation, capillary leak, fluid redistribution, hepatic dysfunction, and exogenous albumin administration. Although hypoalbuminemia is consistently associated with poor outcomes, exogenous human albumin solution (HAS) has not shown a clear survival benefit in septic patients. We therefore investigated whether the prognostic significance of early serum albumin change differs according to whether the change is spontaneous or occurs in the context of HAS administration.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We analyzed septic patients from the MIMIC-IV database and assessed consistency in an independent external cohort from the First Affiliated Hospital of Xi\u2019an Jiaotong University. Delta albumin (\u0394ALB) was defined as the change in serum albumin during the first 3 ICU days. Patients were stratified according to HAS use during this period. The primary outcome was 90-day survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Among patients who did not receive HAS, higher \u0394ALB was significantly associated with lower 90-day mortality risk (HR per 1-g\/dL increase\u202f=\u202f0.50, 95% CI 0.40\u20130.62,\n                      <jats:italic>p<\/jats:italic>\n                      &amp;lt;\u202f0.001), whereas this association was not observed in patients who received HAS. In the external cohort, the absence of a clear prognostic association in albumin-treated patients was directionally consistent, although validation of endogenous \u0394ALB was limited because most patients received HAS. Endogenous \u0394ALB was associated with baseline albumin, hematocrit change, platelet change, crystalloid volume, and liver-related variables, suggesting important influences of hemodilution, illness severity, circulatory status, and hepatic dysfunction.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In the primary MIMIC-IV cohort, spontaneous increases in serum albumin, but not albumin changes among HAS-treated patients, were associated with better outcomes. These findings suggest that early albumin recovery should be interpreted cautiously in nutritional assessment, because its clinical meaning depends on albumin source and on non-nutritional physiological factors rather than nutritional status alone.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fnut.2026.1858939","type":"journal-article","created":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:19:38Z","timestamp":1783570778000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Early serum albumin dynamics in sepsis differ by albumin source and have implications for nutritional assessment"],"prefix":"10.3389","volume":"13","author":[{"given":"Yifei","family":"Ma","sequence":"first","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University","place":["Xi'an, China"]},{"name":"Biobank, The First Affiliated Hospital of Xi'an Jiaotong University","place":["Xi'an, China"]},{"name":"Pancreatic Diseases Center of Xi'an Jiaotong University","place":["Xi'an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kongyuan","family":"Wei","sequence":"additional","affiliation":[{"name":"Pancreatic Diseases Center of Xi'an Jiaotong University","place":["Xi'an, China"]},{"name":"Department of General, Visceral and Transplantation Surgery, University of Heidelberg","place":["Heidelberg, Germany"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqi","family":"Lyu","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University","place":["Xi'an, China"]},{"name":"Pancreatic Diseases Center of Xi'an Jiaotong University","place":["Xi'an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Tang","sequence":"additional","affiliation":[{"name":"Huawei Technologies Co., Ltd.","place":["Xi'an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianyi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Biobank, The First Affiliated Hospital of Xi'an Jiaotong University","place":["Xi'an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingyong","family":"Ma","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University","place":["Xi'an, China"]},{"name":"Pancreatic Diseases Center of Xi'an Jiaotong University","place":["Xi'an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Wen","sequence":"additional","affiliation":[{"name":"Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College","place":["Beijing, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hepatobiliary Surgery, The First Affiliated Hospital of Xi'an Jiaotong University","place":["Xi'an, China"]},{"name":"Pancreatic Diseases Center of Xi'an Jiaotong University","place":["Xi'an, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,9]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"i1585","DOI":"10.1136\/bmj.i1585","article-title":"Sepsis: pathophysiology and clinical management","volume":"353","author":"Gotts","year":"2016","journal-title":"BMJ"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1186\/s13054-019-2478-6","article-title":"Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis","volume":"23","author":"Vincent","year":"2019","journal-title":"Crit Care"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1001\/jama.2014.5804","article-title":"Hospital deaths in patients with sepsis from 2 independent cohorts","volume":"312","author":"Liu","year":"2014","journal-title":"JAMA"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S0140-6736(18)30696-2","article-title":"Sepsis and septic shock","volume":"392","author":"Cecconi","year":"2018","journal-title":"Lancet"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1056\/NEJMp1707170","article-title":"Recognizing Sepsis as a Global Health priority - a WHO resolution","volume":"377","author":"Reinhart","year":"2017","journal-title":"N Engl J Med"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"22","DOI":"10.3390\/ijms22094496","article-title":"Hypoalbuminemia as surrogate and culprit of infections","volume":"22","author":"Wiedermann","year":"2021","journal-title":"Int J Mol Sci"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1016\/j.chest.2016.03.048","article-title":"POINT: should intravenous albumin be used for volume resuscitation in severe sepsis\/septic shock? Yes","volume":"149","author":"Caironi","year":"2016","journal-title":"Chest"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1368","DOI":"10.1016\/j.chest.2016.03.050","article-title":"COUNTERPOINT: should intravenous albumin be used for volume resuscitation in severe sepsis\/septic shock? No","volume":"149","author":"Coz","year":"2016","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"1412","DOI":"10.1056\/NEJMoa1305727","article-title":"Albumin replacement in patients with severe Sepsis or septic shock","volume":"370","author":"Caironi","year":"2014","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.chest.2024.02.049","article-title":"Use of intravenous albumin: a guideline from the international collaboration for transfusion medicine guidelines","volume":"166","author":"Callum","year":"2024","journal-title":"Chest"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1189\/jlb.1008646","article-title":"AGE-modified albumin containing infusion solutions boosts septicaemia and inflammation in experimental peritonitis","volume":"86","author":"Humpert","year":"2009","journal-title":"J Leukoc Biol"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"2297","DOI":"10.1016\/j.clinthera.2019.08.023","article-title":"A cost-effectiveness analysis of albumin in septic shock: a patient-level data analysis","volume":"41","author":"Tigabu","year":"2019","journal-title":"Clin Ther"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.13026\/7vcr-e114.","article-title":"MIMIC-IV (version 2.0)","author":"Johnson","year":"2022","journal-title":"PhysioNet"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"g4561","DOI":"10.1136\/bmj.g4561","article-title":"Randomised trials of human albumin for adults with sepsis: systematic review and meta-analysis with trial sequential analysis of all-cause mortality","volume":"349","author":"Patel","year":"2014","journal-title":"BMJ"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1186\/cc13991","article-title":"Albumin administration in the acutely ill: what is new and where next?","volume":"18","author":"Vincent","year":"2014","journal-title":"Crit Care"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1001\/archinte.1991.00400050051011","article-title":"The use of albumin in clinical practice","volume":"151","author":"Erstad","year":"1991","journal-title":"Arch Intern Med"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.jhep.2013.06.013","article-title":"Oxidative albumin damage in chronic liver failure: relation to albumin binding capacity, liver dysfunction and survival","volume":"59","author":"Oettl","year":"2013","journal-title":"J Hepatol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1111\/liv.12860","article-title":"Ischaemia-modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis","volume":"35","author":"Giannone","year":"2015","journal-title":"Liver Int"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"518","DOI":"10.1038\/nm.3516","article-title":"Immunosuppression in acutely decompensated cirrhosis is mediated by prostaglandin E2","volume":"20","author":"O'Brien","year":"2014","journal-title":"Nat Med"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"575022","DOI":"10.3389\/fphar.2020.575022","article-title":"The effectiveness of clinical pharmacist-led consultation in the treatment of infectious diseases: a prospective, multicenter, cohort study","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Pharmacol"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1080\/17512433.2018.1412827","article-title":"Non-oncotic properties of albumin. A multidisciplinary vision about the implications for critically ill patients","volume":"11","author":"Ferrer","year":"2018","journal-title":"Expert Rev Clin Pharmacol"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa040232","article-title":"A comparison of albumin and saline for fluid resuscitation in the intensive care unit","volume":"350","author":"Finfer","year":"2004","journal-title":"N Engl J Med"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1002\/ncp.10588","article-title":"The use of visceral proteins as nutrition markers: an ASPEN position paper","volume":"36","author":"Evans","year":"2021","journal-title":"Nutr Clinic Pract"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"104318","DOI":"10.1016\/j.ebiom.2022.104318","article-title":"Current sepsis therapeutics","volume":"86","author":"Vincent","year":"2022","journal-title":"EBioMedicine"}],"container-title":["Frontiers in Nutrition"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1858939\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:19:39Z","timestamp":1783570779000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fnut.2026.1858939\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,9]]},"references-count":24,"alternative-id":["10.3389\/fnut.2026.1858939"],"URL":"https:\/\/doi.org\/10.3389\/fnut.2026.1858939","relation":{},"ISSN":["2296-861X"],"issn-type":[{"value":"2296-861X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,9]]},"article-number":"1858939"}}